EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Liposomal AntagomiR ‐155‐5p Restores Anti‐Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid Arthritis

Audrey Paoletti iD, Bineta Ly, Catherine Cailleau, Fan Gao, Marie Péan de Ponfilly-Sotier, Juliette Pascaud, Elodie Rivière, Luxin Yang, Lilian Nwosu, Aziza Elmesmari, Franceline Reynaud, Magali Hita und 9 weitere

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Audrey Paoletti und 20 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Saclay University, INSERM UMR1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin Bicêtre, France. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Arthritis, Experimental, MicroRNAs. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Versus Arthritis, Medical Research Council, Foundation for Research in Rheumatology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We previously reported an increased expression of microRNA‐155 (miR‐155) in the blood monocytes of patients with rheumatoid arthritis (RA) that could be responsible for impaired monocyte polarization to anti‐inflammatory M2‐like macrophages. In this study, we employed two preclinical models of RA, collagen‐induced arthritis and K/BxN serum transfer arthritis, to examine the therapeutic potential of antagomiR‐155‐5p entrapped within PEGylated (polyethylene glycol [PEG]) liposomes in resolution of arthritis and repolarization of monocytes towards the anti‐inflammatory M2 phenotype.

Methods

AntagomiR‐155‐5p or antagomiR‐control were encapsulated in PEG liposomes of 100 nm in size and −10 mV in zeta potential with high antagomiR loading efficiency (above 80%). Mice were injected intravenously with 1.5 nmol/100 μL PEG liposomes containing antagomiR‐155‐5p or control after the induction of arthritis.

Results

We demonstrated the biodistribution of fluorescently tagged PEG liposomes to inflamed joints one hour after the injection of fluorescently tagged PEG liposomes, as well as the liver's subsequent accumulation after 48 hours, indicative of hepatic clearance, in mice with arthritis. The injection of PEG liposomes containing antagomiR‐155‐5p decreased arthritis score and paw swelling compared with PEG liposomes containing antagomiR‐control or the systemic delivery of free antagomiR‐155‐5p. Moreover, treatment with PEG liposomes containing antagomiR‐155‐5p led to the restoration of bone marrow monocyte defects in anti‐inflammatory macrophage differentiation without any significant functional change in other immune cells, including splenic B and T cells.

Conclusion

The injection of antagomiR‐155‐5p encapsulated in PEG liposomes allows the delivery of small RNA to monocytes and macrophages and reduces joint inflammation in murine models of RA, providing a promising strategy in human disease. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidArthritis, ExperimentalMicroRNAsHumansMiceAnimalsAntagomirsLiposomesTissue DistributionMacrophagesAnti-Inflammatory Agents

Substanzen

AntagomirsLiposomesAnti-Inflammatory AgentsMIRN155 microRNA, humanMicroRNAsMirn155 microRNA, mouse

Autor:innen und Institutionen

  • Paris-Saclay University, INSERM UMR1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin Bicêtre, France.
  • Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, France.
  • Division of Biomedical Engineering, James Watt School of Engineering, University of Glasgow, Glasgow, United Kingdom.
  • School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom.
  • Rheumatology Department, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, Le Kremlin Bicêtre, France.

ORCID-Profile: Audrey Paoletti, Gaetane Nocturne, Iain B McInnes, Xavier Mariette

Förderung

  • Versus Arthritis
  • Medical Research Council
  • Foundation for Research in Rheumatology

Zitieren

APA

Paoletti, A., Ly, B., Cailleau, C., Gao, F., de Ponfilly-Sotier, M. P., Pascaud, J., Rivière, E., Yang, L., Nwosu, L., Elmesmari, A., Reynaud, F., Hita, M., Paterson, D., Reboud, J., Fay, F., Nocturne, G., Tsapis, N., McInnes, I. B., Kurowska-Stolarska, M., …, & Mariette, X. (2024). Liposomal AntagomiR ‐155‐5p Restores Anti‐Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid Arthritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.42665

Vancouver

Paoletti A, Ly B, Cailleau C, Gao F, de Ponfilly-Sotier MP, Pascaud J, et al. Liposomal AntagomiR ‐155‐5p Restores Anti‐Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid Arthritis. Arthritis & Rheumatology. 2024. doi:10.1002/art.42665

BibTeX
@article{Paoletti2024,
  author = {Paoletti, Audrey and Ly, Bineta and Cailleau, Catherine and Gao, Fan and de Ponfilly-Sotier, Marie Péan and Pascaud, Juliette and Rivière, Elodie and Yang, Luxin and Nwosu, Lilian and Elmesmari, Aziza and Reynaud, Franceline and Hita, Magali and Paterson, David and Reboud, Julien and Fay, Francois and Nocturne, Gaetane and Tsapis, Nicolas and McInnes, Iain B and Kurowska-Stolarska, Mariola and Fattal, Elias and Mariette, Xavier},
  title = {Liposomal AntagomiR ‐155‐5p Restores Anti‐Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42665}
}
Kostenlos starten →